biote (BTMDW) Stock Price, News & Analysis

Company Overview

Biote Corp., trading under the symbol BTMDW on the Nasdaq, is a specialized provider of hormone optimization and telehealth services aimed at improving patient wellness. The company’s core offering centers on bioidentical hormone replacement therapy (BHRT), delivered primarily through subcutaneous pellet implants. These pellets are custom-dosed for individual patients to help address hormone imbalances associated with aging, menopause, and andropause.

In addition to pellet therapy, Biote offers an integrated telehealth platform that enables virtual consultations, at-home hormone testing, and ongoing patient monitoring. The company’s membership model provides patients with access to healthcare providers, treatment plans, and supplemental nutraceutical products such as vitamin D and multivitamin formulations designed to support overall health. This end-to-end service model allows Biote to maintain direct relationships with patients throughout their treatment journey.

Founded in 2014 and headquartered in Phoenix, Arizona, Biote serves patients across the United States through a network of licensed healthcare practitioners and partner clinics. The company leverages digital tools and remote diagnostics to expand its reach beyond traditional brick-and-mortar settings, positioning itself as a telemedicine leader in the women’s and men’s health markets. Biote’s platform is designed to scale with growing demand for personalized, hormone-focused care delivered outside of conventional medical environments.

Key Stats

• Today's Range: $0.0026 to $0.0145
• 50-Day Range: $0.0026 to $0.0125
• 52-Week Range: $0.05 to $1.68
• Volume: 2.48 million shs
• Average Volume: 58,814 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Manufacturing
• Industry: Medicinal Chemicals
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:BTMDW
• CIK: 1819253
• Web: biote.com
• Phone: 844 604 1246
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $195.65 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A